Bluesky Facebook Reddit Email

Treating type 1 diabetes in mice

11.23.20 | Proceedings of the National Academy of Sciences

SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

Type 1 diabetes (T1D) is marked by the autoimmune destruction of insulin-secreting beta cells in the pancreas, and a study finds that in a mouse model of T1D an approach combining haploidentical mixed chimersim, which involves transplanting hematopoietic cells from a parent or sibling using an optimized procedure, and administration of both the peptide hormone gastrin, which boosts beta cell mass, and epidermal growth factor, which promotes pancreatic epithelial cell growth, reversed autoimmunity, augmented beta cell regeneration, and normalized blood glucose levels by reactivating dysfunctional beta cells and transforming alpha cells into insulin-secreting beta cells, according to the authors.

Article #20-12389: "Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD mice," by Shanshan Tang et al.

MEDIA CONTACT: Letisia Marquez, City of Hope, Duarte, CA; tel: 626-476-7593; e-mail: lemarquez@coh.org

###

Proceedings of the National Academy of Sciences

Keywords

Article Information

Contact Information

Letisia Marquez
lemarquez@coh.org

How to Cite This Article

APA:
Proceedings of the National Academy of Sciences. (2020, November 23). Treating type 1 diabetes in mice. Brightsurf News. https://www.brightsurf.com/news/L59E63R8/treating-type-1-diabetes-in-mice.html
MLA:
"Treating type 1 diabetes in mice." Brightsurf News, Nov. 23 2020, https://www.brightsurf.com/news/L59E63R8/treating-type-1-diabetes-in-mice.html.